Loading live market data…

Aurinia Pharmaceuticals Inc.

NASDAQ:AUPH

$16.1 USD

$0.12 (0.75%)

Volume
930.28K
Average Volume
1.51M
Market Capitalization
$2.07B
P/E Ratio
7.19
Dividend Yield
0.00%
Price Target
$13.00
Year High
$19.25
Year Low
$8.55
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$5.55

AUPH Estimated and Actual Revenue by Quarter

AUPH Estimated and Actual EPS by Quarter

AUPH Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-12-31 3 -28.39M -25.56M -26.61M -32.1M -28.9M -30.09M
2026-09-30 4 -27.02M -24.33M -25.68M -30.55M -27.51M -29.03M
2026-06-30 4 -25.81M -24.25M -25.03M -29.18M -27.42M -28.3M
2026-03-31 5 -24.02M -23.47M -23.81M -27.16M -26.53M -26.92M
2025-12-31 5 -23.5M -22.89M -23.1M -26.57M -25.87M -26.12M
2025-09-30 5 -21.74M -20.3M -20.94M -24.59M -22.96M -23.67M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-12-31 3 31.6M 36.2M 33.31M 122.77M 136.36M 127.83M
2026-09-30 4 31.33M 35.9M 33.03M 116.86M 129.79M 123.32M
2026-06-30 4 30.14M 34.89M 33.31M 116.47M 123.97M 120.22M
2026-03-31 5 23.86M 29.82M 26.84M 112.72M 115.38M 114.34M
2025-12-31 5 25.56M 35.5M 29.82M 109.92M 112.89M 110.95M
2025-09-30 5 20.65M 23.93M 22.02M 97.52M 104.44M 100.56M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-12-31 3 82.65M 91.8M 86.06M 1 0.22955 0.263 0.242
2026-09-30 4 78.67M 87.38M 83.03M 2 0.22765 0.26082 0.24
2026-06-30 4 78.41M 83.46M 80.94M 3 0.21895 0.25352 0.242
2026-03-31 5 75.88M 77.67M 76.98M 3 0.17333 0.21667 0.195
2025-12-31 5 74M 76M 74.7M 4 0.18572 0.25794 0.21667
2025-09-30 5 65.66M 70.31M 67.7M 4 0.15 0.17388 0.16